Healthcare - Medika Life

The first antiviral nasal spray in the United States. Nomovid™ Nasal Spray will be easy-to-use, low-cost and can be quickly made available over-the-counter for consumers.

Control, There Are Reasons to Smile

Pat Farrell PhD - December 11, 2021

Smiling has been shown to have a positive mode-enhancing ability.

Too Much of a Good Thing

Richard Hatzfeld - March 9, 2023

Antimicrobial resistance is not an American problem; it is a threat shared by every country

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

At HLTH Europe, Briya Opens No-Cost Access to AI-Powered Research

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Health Innovation Has a Friction Problem

The Value of Health AI Conferences Is No Longer the Stage. It’s the Hallway Conversation

LATEST

TRENDING

Video of Jordon Walker, Supposed Pfizer Researcher, Goes Viral

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Is Your Covid Test Being Used to Covertly Harvest Your DNA?

The Medika Life Top 30 Voices Transforming Wellness for 2022/23

Medika’s Top 20 AI Voices to Watch. Follow These Experts as They Demystify AI and Its Future

The Medika Life 50 – The Most Influential Voices in Health for 2022

Women Transforming Healthcare: The Medika Life 2022 Top 30

Is the Covid Vaccine’s Spike Protein Killing Us?

Pudendal and Paracervical Blocks

Fifty of the Most Influential Voices in Healthcare for 2021

EDITORS CHOICE

Why I Still Wear a Mask

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Control, There Are Reasons to Smile

Too Much of a Good Thing

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories